Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02197 CLOVER BIO-B > Detailed Quotes

02197 CLOVER BIO-B

Watchlist
2.700
+0.170+6.72%
Closed  02/01 16:08 CCT
High
2.760
Open
2.550
Turnover
60.29M
Low
2.540
Pre Close
2.530
Volume
22.60M
Market Cap
3.49B
P/E(TTM)
Loss
52wk High
12.560
Shares
1.29B
P/E(Static)
Loss
52wk Low
1.600
Float Cap
3.49B
Bid/Ask %
-59.54%
Historical High
14.800
Shs Float
1.29B
Volume Ratio
2.17
Historical Low
1.600
Dividend TTM
--
Div Yield TTM
--
P/B
16.88
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.75%
Amplitude
8.70%
Avg Price
2.668
Lot Size
500
Float Cap
3.49B
Bid/Ask %
-59.54%
Historical High
14.800
Shs Float
1.29B
Volume Ratio
2.17
Historical Low
1.600
Dividend TTM
--
P/B
16.88
Dividend LFY
--
Turnover Ratio
1.75%
Amplitude
8.70%
Avg Price
2.668
Lot Size
500
Price Forecast

News

Comment

Company Overview More
We are a clinical-stage global biopharmaceutical company dedicated to developing novel vaccines and biotherapeutics. Our vision is a future that empowers humanity to be healthier through transformative science. Our mission is to discover, develop and commercialize novel vaccines and biotherapeutics based on the Trimer-TAGTM technology platform and our manufacturing capabilities. Since our establishment in 2007, we have focused on transforming cutting-edge science to address the huge unmet medical needs. Originating from the TrimerTagTM technology platform, we built our own R&D capabilities in Chengdu, Sichuan Province, China, and established a commercial-scale production base in Changxing, Zhejiang Province, China. In the process, we have formed and continued to build a world-class team, making the company the organization it is today.
CEO: Peng Liang
Market: Hong Kong motherboard
Listing Date: 11/05/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist